Anebulo Pharmaceuticals Statistics
Total Valuation
ANEB has a market cap or net worth of $39.42 million. The enterprise value is $38.01 million.
| Market Cap | 39.42M |
| Enterprise Value | 38.01M |
Important Dates
The last earnings date was Wednesday, November 13, 2024, after market close.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ANEB has 25.93 million shares outstanding. The number of shares has increased by 1.05% in one year.
| Current Share Class | 25.93M |
| Shares Outstanding | 25.93M |
| Shares Change (YoY) | +1.05% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 64.22% |
| Owned by Institutions (%) | 7.63% |
| Float | 3.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 20.76 |
| P/TBV Ratio | 20.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.45
| Current Ratio | 3.45 |
| Quick Ratio | 2.90 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -38.77 |
Financial Efficiency
Return on equity (ROE) is -154.87% and return on invested capital (ROIC) is -99.92%.
| Return on Equity (ROE) | -154.87% |
| Return on Assets (ROA) | -88.76% |
| Return on Capital (ROIC) | -99.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.64M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.63% in the last 52 weeks. The beta is -1.01, so ANEB's price volatility has been lower than the market average.
| Beta (5Y) | -1.01 |
| 52-Week Price Change | -29.63% |
| 50-Day Moving Average | 1.89 |
| 200-Day Moving Average | 2.29 |
| Relative Strength Index (RSI) | 39.06 |
| Average Volume (20 Days) | 5,659 |
Short Selling Information
The latest short interest is 10,758, so 0.04% of the outstanding shares have been sold short.
| Short Interest | 10,758 |
| Short Previous Month | 11,565 |
| Short % of Shares Out | 0.04% |
| Short % of Float | 0.27% |
| Short Ratio (days to cover) | 1.94 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.18M |
| Pretax Income | -9.35M |
| Net Income | -7.92M |
| EBITDA | n/a |
| EBIT | -8.18M |
| Earnings Per Share (EPS) | -$0.31 |
Balance Sheet
| Cash & Cash Equivalents | 1.40M |
| Total Debt | n/a |
| Net Cash | 1.40M |
| Net Cash Per Share | $0.05 |
| Equity (Book Value) | 1.90M |
| Book Value Per Share | 0.07 |
| Working Capital | 1.39M |
Cash Flow
| Operating Cash Flow | -7.05M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.05M |
| FCF Per Share | -$0.27 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ANEB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.05% |
| Shareholder Yield | -1.05% |
| Earnings Yield | -20.10% |
| FCF Yield | -17.90% |
Analyst Forecast
The average price target for ANEB is $8.00, which is 426.32% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.00 |
| Price Target Difference | 426.32% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |